コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lution conditions and clonogenic activity in soft agar.
2 ters growth properties and induces growth in soft agar.
3 lls enhanced anchorage-independent growth in soft agar.
4 in the spontaneous formation of colonies in soft agar.
5 ed cells and anchorage-independent growth in soft agar.
6 cacy using two non-tumorigenic cell lines in soft agar.
7 d and several were able to inhibit growth in soft agar.
8 ttenuating their ability to form colonies in soft agar.
9 endent growth of gastric epithelial cells in soft agar.
10 activation, and inhibits the cell growth in soft agar.
11 resensitizes the DDR and restrains growth in soft agar.
12 -dependent tumor cell motility and growth in soft agar.
13 of colony formation, and impaired growth in soft agar.
14 ut had little effect on swimming motility in soft agar.
15 re necessary for TGF-beta-mediated growth in soft agar.
16 , resulting in increased colony formation in soft agar.
17 fewer colonies in both monolayer culture and soft agar.
18 n potential, assessed by colony formation in soft agar.
19 zomib inhibited estrogen-dependent growth in soft agar.
20 etic basement membranes, and their growth in soft agar.
21 UMUC3) were dependent on FGFR1 for growth in soft agar.
22 on and prostate cancer cell colony growth in soft agar.
23 mary epithelial cells caused their growth in soft agar.
24 ing in a viscous medium or on the surface of soft agar.
25 d growth of human glioblastoma T98G cells in soft agar.
26 ayer culture and growth of large colonies in soft agar.
27 one induced little or no colony formation in soft agar.
28 chment conditions analogous to growth in the soft agar.
29 d by a screen for restoration of motility in soft agar.
30 as assessed by measuring colony formation in soft agar.
31 f multiple Wnt-addicted cancer cell lines in soft agar.
32 feration and anchorage-independent growth in soft agar.
33 s tumor cell anchorage-independent growth in soft agar.
34 cancer, BT-20 cells do not form colonies in soft agar.
35 n to inhibit anchorage-independent growth in soft agar.
36 BT-20 cells the ability to form colonies in soft agar.
37 sform primary mouse embryonic fibroblasts in soft agar.
38 roliferation, colony formation and growth in soft agar.
39 erin levels, and reduced colony formation in soft agar.
40 and reduced clonogenicity on plastic and in soft agar.
41 cultures and anchorage-independent growth in soft agar.
42 feration and anchorage-independent growth on soft agar.
43 orage-independent growth of cell colonies on soft agar.
44 red by the ability to form large colonies in soft agar.
45 ells reduces anchorage-independant growth in soft agar.
46 mation in mice, as well as foci formation in soft agar.
47 f v-Rel transformed CEFs to form colonies in soft agar.
48 binant retrovirus suppressed their growth in soft agar.
49 eration, and anchorage-independent growth in soft agar.
50 ble to inhibit HC11-Int3 colony formation in soft agar.
51 59 led to a reduction of colony formation in soft agar.
52 TT assay and anchorage-independent growth in soft agar.
53 tion of the MNKs reduces colony formation in soft agar.
54 melanoma proliferation in both monolayer and soft agar.
55 medium-stimulated epithelial cell growth in soft agar.
56 ted spontaneous mutants able to move through soft agar.
57 s to form xenografts in mice and colonies in soft agar.
58 leus, an overgrowth phenotype, and growth in soft agar.
59 ent on IRS1 activity for colony formation in soft agar.
60 growth and migration and colony formation in soft agar.
61 nes enhances the ability to form colonies in soft agar.
62 of prostate cancer cells to form colonies in soft agar.
63 ration but essential for colony formation in soft agar.
64 cell transformation as assessed by growth in soft agar.
67 cells and monitored its effects on growth in soft agar, a hallmark of cellular transformation, and al
71 morigenic phenotype with increased growth in soft agar and an invasive phenotype in three-dimensional
72 44, and displayed increased clonogenicity in soft agar and broad drug-resistance in vitro and in vivo
73 and FLLL32 also inhibit colony formation in soft agar and cell invasion and exhibit synergy with the
74 nhibition of anchorage-independent growth in soft agar and cell migration in each of four NSCLC lines
76 c Mullerian epithelial marker genes, grow in soft agar and develop ectopic invasive tumors in recipie
77 s, increased anchorage-independent growth in soft agar and enhanced tumor growth in severe combined i
79 so inhibited anchorage-independent growth in soft agar and growth in an orthotopic xenograft model.
82 density, and acquired the ability to grow in soft agar and in Matrigel compared with the parental rel
84 roliferation, migration, invasion, growth in soft agar and in vivo tumorigenicity, whereas downregula
85 he ability of neuroblastoma cells to grow in soft agar and induce tumors in immunodeficient mice.
86 ability of neurospheres to form colonies in soft agar and inhibited their capacity to propagate subc
87 H1299 lung cancer cells inhibited growth in soft agar and invasive colony formation in Matrigel and
88 h the MAPK inhibitor U0216 reduced growth in soft agar and invasive phenotype, whereas the combinatio
93 mediated CTSD induction, inhibited growth in soft agar and partially restored tamoxifen sensitivity o
94 Long-term-infected TIVE cells (LTC) grew in soft agar and proliferated under reduced-serum condition
95 ir growth rate, enhanced colony formation in soft agar and promoted tumor formation in nude mice.
96 d cells contained HPV-16, formed colonies in soft agar and rapidly produced tumors in immunodeficient
97 ased cell proliferation, colony formation in soft agar and strikingly diminished cell migration and i
98 mutant mtDNA were tested by growth assay in soft agar and subcutaneous implantation of the cells in
99 breast cancer cells in liquid culture and in soft agar and suppresses the tumorigenicity of MCF-7 cel
100 of tumor cell growth and colony formation in soft agar and the extent of such inhibition appeared to
101 cell lines (R(-)3) formed large colonies in soft agar and the transformation of these T antigen-expr
102 utant failed to exhibit swarming motility on soft agar and this phenotype was rescued by a plasmid-bo
108 epidermoid cancer cells inhibited growth in soft agar and tumorigenesis in nude mice, and suppressed
111 insult formed significantly more colonies in soft agar and were significantly more invasive when grow
113 ed in the transformation of keratinocytes in soft agar and xenograft establishment, thus also implica
114 eration and reduced both colony formation in soft agar and xenograft tumor growth in immunodeficient
115 rmation activity (focus formation, growth in soft agar) and activation of PI3K and MAPK signaling.
116 rongly stimulated cell growth in culture, in soft agar, and accelerated tumor formation in a ligand i
119 of transformed cells to form clones, grow in soft agar, and form tumors in severe combined immunodefi
120 igher growth rate, produced more colonies in soft agar, and formed larger tumor upon xenograft inject
124 um, enhanced anchorage-independent growth in soft agar, and increased tumorigenicity in nonobese diab
125 feration, enhanced tumor colony formation in soft agar, and increased xenograft tumor growth in nude
128 osis in culture, reduced colony formation in soft agar, and inhibited invasion of melanoma cells.
129 ced apoptosis, abolished colony formation in soft agar, and inhibited localized and metastatic tumor
130 pe, acquired anchorage-independent growth in soft agar, and led to enlarged, disorganized, three-dime
131 dine decreased cell proliferation, growth in soft agar, and methylcytosine content of malignant chola
132 V-induced proliferation, colony formation in soft agar, and NO generation of KSHV-transformed cells,
136 oliferation, anchorage-independent growth in soft agar, and tumorigenesis in severe combined immunode
139 of cell proliferation, migration, growth in soft agar, apoptosis, senescence, and gene expression re
142 w the anticancer activity of SC66 by using a soft agar assay as well as a mouse xenograft tumor model
151 ntified and tumorigenesis was assessed using soft agar assays and xenograft analysis of severe combin
153 A has transforming activities when tested in soft agar assays, and CoAA is homologous to oncoproteins
162 anchorage-independent growth by conducting a soft agar-based short hairpin RNA (shRNA) screen within
163 hibits Src-Y527F-induced colony formation in soft agar, but not Ras-G12V-induced colony formation.
164 y formation, anchorage-independent growth in soft agar, cell migration, and epithelial-mesenchymal tr
165 ates of cell proliferation, clonogenicity in soft agar, changes in the actin cytoskeleton, and induct
166 additional novel DNA methylation targets in soft-agar clones derived from CSC-exposed HBEC; a CSC ge
168 1 in cultured SCLC resulted in inhibition of soft agar clonogenic capacity and induction of apoptosis
169 d tumor cells showed significantly increased soft-agar clonogenic ability and tumor sphere formation.
175 nhibited but were unable to efficiently form soft-agar colonies or tumor xenografts, suggesting that
178 rming Matrigel invasion, cell proliferation, soft agar colony formation and scratch closure assays.
181 cells and mouse epidermal JB6 cells promoted soft agar colony formation by downregulating Pdcd4 prote
183 d with reduced in vitro proliferation rates, soft agar colony formation efficiency, and migration rat
184 lls by TSC2 siRNA, and decreased Myc-induced soft agar colony formation following retroviral transduc
185 t FGF19 could promote cell proliferation and soft agar colony formation in HNSCC cells with low FGF19
186 growth factor-independent proliferation and soft agar colony formation in MCF10A cells, and hLsm1 in
188 of profibrotic targets, cell migration, and soft agar colony formation stimulated by TGF-beta requir
189 ransition) signaling, transwell invasion and soft agar colony formation, and in vivo promoted lung me
190 ets of miR-7, reduced cell proliferation and soft agar colony formation, and increased apoptosis.
191 associated with altered cellular phenotypes, soft agar colony formation, and tumorigenesis in nude mi
192 2-yl)-2,5-diphenyltetrazolium bromide assay, soft agar colony formation, as well as tumor growth in a
193 ificantly suppresses cell growth in culture, soft agar colony formation, cell invasion and growth of
194 ion of wild-type full-length TMEFF2 inhibits soft agar colony formation, cellular invasion, and migra
195 sive SK-N-SH neuroblastoma cells resulted in soft agar colony formation, which was inhibited by a GRP
196 ells led to decreased transwell invasion and soft agar colony formation, without affecting proliferat
200 C downregulation increased cell invasion and soft agar colony formation; this was dependent on NF-kap
201 co-expression of PEA-15 resulted in enhanced soft agar colony growth and increased tumor growth in vi
204 enhancement of cell proliferation, increased soft agar colony size, and elevated ERK1/2 phosphorylati
205 lls and completely blocks their invasive and soft agar colony-forming abilities, but it spares nontra
207 SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in
208 but not CRAF WT, transformed NIH3T3 cells in soft-agar colony formation assays, increased kinase acti
210 c cooperate in suppressing proliferation and soft-agar colony formation of neoplastic epithelial ovar
211 in vitro proliferation, migration, invasion, soft-agar colony formation, and survival in the presence
212 ckdown of CDH10 promoted cell proliferation, soft-agar colony formation, cell migration and cell inva
215 NT-3 promoted motility, migration, invasion, soft-agar colony growth and cytoskeleton restructuring i
216 re also increased cell growth as assessed by soft-agar colony survival and cell growth assays, and pr
219 invasion, motility, and colony formation in soft agar compared with vector control-transfected cells
222 ced SmgGDS expression form fewer colonies in soft agar, do not proliferate in culture due to an arres
223 These cells when trypsinized and regrown in soft agar, formed colonospheres/organoids that developed
224 melanocytes grew anchorage-independently in soft agar, formed pigmented lesions reminiscent of in si
225 neuploidy, and amplified colony formation in soft agar, further supporting the role of CHFR as a tumo
226 nement of a worm between a glass plate and a soft agar gel is controlled while recording the worm's m
227 x2 was necessary for its ability to increase soft agar growth and in vivo metastasis in an immunocomp
228 n of ZNF322A promoted cell proliferation and soft agar growth by prolonging cell cycle in S phase in
229 from CAN-genes, and experimentally verifying soft agar growth enhancement in response to depletion of
230 r in combination and observed the effects on soft agar growth of HC11 cells overexpressing Int3.
231 f the ITSN1 target, PI3K-C2beta, rescues the soft agar growth of ITSN1-silenced cells demonstrating t
232 owth inhibitory effects of TGF-beta, and the soft agar growth of these cells was increased upon TGF-b
234 d signaling pathways regulate proliferation, soft agar growth, and invasion of human lung adenocarcin
235 essed HBECs toward malignancy as measured by soft agar growth, including EGF-independent growth, but
236 ted resistance to redox stress and increased soft agar growth, while downregulation of SQSTM1 decreas
240 ble knockdown of SLFN2 form more colonies in soft agar, implicating this protein in the regulation of
242 in human melanoma cells inhibited growth on soft agar in vitro and tumor formation in vivo, suggesti
243 ) cells enhanced proliferation and growth in soft agar in vitro but was insufficient to drive tumorig
245 e Escherichia coli populations in semisolid (soft) agar in the concentration range C = 0.15-0.5% (w/v
246 ed increased anchorage-independent growth in soft agar, increased S-phase cell cycle distribution, in
247 creased Wnt activity and colony formation in soft agar induced by Apc siRNA treatment, whereas they d
248 f tumor cell anchorage-independent growth in soft agar, induction of the p130Cas cleavage, and anoiki
249 al for malignant transformation according to soft agar, invasion, and tumorigenicity assays, after th
250 he ability of breast cancer cells to grow in soft agar is enhanced following GREB1 transfection.
253 catechin-3-gallate (EGCG) inhibits growth in soft agar of breast cancer cells with Her-2/neu overexpr
255 d cell proliferation and colony formation in soft agar of KSHV-transformed cells by attenuating mTORC
257 es individually promoted colony formation in soft agar or collaborated with each other functionally.
262 strain G27 resulted in decreased motility on soft agar plates, a defect that was complemented by a wi
264 rly flagellated counterparts in spreading on soft-agar plates and through medium-filled channels desp
265 gand-independent proliferation and growth in soft agar relative to cells expressing wt PR-B or phosph
267 ack EP2 expression prevented their growth in soft agar, restored their cytostatic response to TGF-bet
268 ever, including impaired colony formation in soft agar, spheroid formation, and xenograft growth.
269 genesis as measured by growth of colonies in soft agar, spheroids in extracellular matrix and xenogra
270 orage-independent cell transformation assay (soft agar), stable expression of RSK2 in JB6 cells signi
271 iferation, promoted formation of colonies in soft agar, stimulated tumor cell invasion, and induced l
272 opment of compact multicellular spheroids in soft agar suggesting the ability to induce anchorage-ind
273 d prostate cells enabled colony formation in soft agar, suggesting that, in the proper cellular conte
274 -ras allele consistently increased growth in soft agar, suggesting tumor-suppressive properties of th
276 , AgmU-mCherry clusters were not observed on soft agar surfaces or when cells were in large groups, c
277 g GRP78 and Cripto grow much more rapidly in soft agar than do cells expressing either protein indivi
278 significantly fewer and smaller colonies in soft agar than their 2D-irradiated counterparts (gamma P
279 ant transformation, as measured by growth in soft agar, the gold-standard in vitro transformation ass
280 93a controls anchorage-independent growth in soft agar through K-Ras, whereas it affects invasive gro
282 e, as shown by increased colony formation in soft agar, tumor formation in SCID (severe combined immu
283 invasion and anchorage-independent growth in soft agar, two fundamental biological events associated
284 ersely, silencing RBM3 or culturing cells in soft agar (under conditions that enrich for stem cell-li
285 PTEN into PEL inhibited colony formation in soft agar, verifying the functional dependence of PEL on
287 y, swarming from colonies grown on MacConkey soft agar was delayed in the mutant in comparison to the
290 colonies of the NSCLC cell line, H1,299, in soft agar was strongly inhibited by the Abl kinase inhib
291 li in liquid and embedded in glucose-limited soft agar, we evaluate the fit of this model to experime
293 prevents HeLa cells from forming colonies in soft agar, when paxillin is knocked down together with C
294 e cells), and these cells formed colonies in soft agar, whereas BCR-ABL+ NIH 3T3 cells lacking IL-3 r
295 s promotes their ability to form colonies in soft agar, whereas ectopically expressing paxillin in th
296 ll lines to proliferate and form colonies in soft agar, whereas EWSAT1 inhibition had no effect on ot
297 ion through collagen and decreased growth in soft agar, whereas the second was enriched in cells with
298 nduced colony formation of JB6 Cl41 cells in soft agar, which was associated with inhibition of histo
299 o stimulated cancer cell colony formation in soft agar, which was reduced by a chemical inhibitor of